Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Optic Neuritis | 15 | 2024 | 173 | 8.300 |
Why?
|
Neuromyelitis Optica | 5 | 2023 | 257 | 2.650 |
Why?
|
Papilledema | 6 | 2023 | 126 | 2.640 |
Why?
|
Orbital Myositis | 3 | 2020 | 26 | 2.050 |
Why?
|
Optic Nerve Diseases | 5 | 2023 | 335 | 1.700 |
Why?
|
Lyme Neuroborreliosis | 2 | 2024 | 50 | 1.650 |
Why?
|
Susac Syndrome | 2 | 2023 | 22 | 1.620 |
Why?
|
Pseudotumor Cerebri | 3 | 2022 | 105 | 1.520 |
Why?
|
Vision Disorders | 8 | 2023 | 1064 | 1.410 |
Why?
|
Cluster Headache | 2 | 2020 | 53 | 1.350 |
Why?
|
Meningitis | 3 | 2021 | 215 | 1.350 |
Why?
|
Vasculitis | 2 | 2023 | 520 | 1.220 |
Why?
|
Aquaporin 4 | 4 | 2022 | 157 | 1.110 |
Why?
|
Neurology | 2 | 2024 | 767 | 0.960 |
Why?
|
Optic Nerve | 6 | 2022 | 563 | 0.960 |
Why?
|
Visual Fields | 2 | 2020 | 1038 | 0.900 |
Why?
|
Cranial Nerve Diseases | 1 | 2024 | 110 | 0.890 |
Why?
|
Autoantibodies | 6 | 2023 | 2044 | 0.890 |
Why?
|
Dyskinesias | 1 | 2023 | 81 | 0.870 |
Why?
|
Chickenpox | 1 | 2023 | 96 | 0.850 |
Why?
|
Encephalitis, Varicella Zoster | 1 | 2022 | 8 | 0.840 |
Why?
|
Retinal Artery Occlusion | 1 | 2023 | 79 | 0.840 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 21 | 0.790 |
Why?
|
Confusion | 1 | 2023 | 272 | 0.780 |
Why?
|
Headache Disorders | 1 | 2024 | 138 | 0.780 |
Why?
|
Intracranial Pressure | 2 | 2021 | 321 | 0.770 |
Why?
|
Nelson Syndrome | 1 | 2021 | 20 | 0.770 |
Why?
|
Leukoencephalopathies | 1 | 2024 | 247 | 0.760 |
Why?
|
Eye Hemorrhage | 1 | 2020 | 19 | 0.750 |
Why?
|
Abducens Nerve Diseases | 1 | 2021 | 42 | 0.730 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2021 | 50 | 0.730 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 63 | 0.720 |
Why?
|
Cranial Fossa, Posterior | 1 | 2021 | 134 | 0.720 |
Why?
|
Blepharoptosis | 1 | 2021 | 141 | 0.710 |
Why?
|
PrPSc Proteins | 1 | 2019 | 32 | 0.700 |
Why?
|
Retinoids | 1 | 2020 | 100 | 0.690 |
Why?
|
Facial Paralysis | 1 | 2024 | 344 | 0.690 |
Why?
|
Herpes Zoster | 1 | 2022 | 240 | 0.690 |
Why?
|
Blepharospasm | 1 | 2019 | 29 | 0.690 |
Why?
|
Paresis | 1 | 2021 | 175 | 0.680 |
Why?
|
Niemann-Pick Disease, Type C | 1 | 2019 | 49 | 0.670 |
Why?
|
Autoimmune Diseases | 3 | 2021 | 2193 | 0.670 |
Why?
|
Cerebral Amyloid Angiopathy | 3 | 2021 | 868 | 0.660 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2019 | 91 | 0.660 |
Why?
|
Spinocerebellar Ataxias | 1 | 2019 | 99 | 0.630 |
Why?
|
Orbital Pseudotumor | 1 | 2018 | 41 | 0.630 |
Why?
|
Vascular Neoplasms | 1 | 2020 | 170 | 0.630 |
Why?
|
Encephalitis | 1 | 2022 | 428 | 0.630 |
Why?
|
Ocular Motility Disorders | 1 | 2019 | 141 | 0.620 |
Why?
|
Coronavirus | 1 | 2020 | 150 | 0.610 |
Why?
|
Lyme Disease | 1 | 2024 | 620 | 0.610 |
Why?
|
Craniopharyngioma | 1 | 2020 | 278 | 0.600 |
Why?
|
Blindness | 3 | 2021 | 582 | 0.590 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 269 | 0.590 |
Why?
|
Ataxia | 1 | 2019 | 304 | 0.580 |
Why?
|
Multiple Sclerosis | 2 | 2023 | 3132 | 0.570 |
Why?
|
Skull Base | 1 | 2019 | 288 | 0.560 |
Why?
|
Optic Disk | 2 | 2021 | 417 | 0.560 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2019 | 388 | 0.540 |
Why?
|
Magnetic Resonance Imaging | 13 | 2023 | 35781 | 0.510 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3054 | 0.470 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3166 | 0.470 |
Why?
|
Eye Diseases | 2 | 2021 | 642 | 0.440 |
Why?
|
Retina | 2 | 2023 | 2615 | 0.430 |
Why?
|
Pandemics | 4 | 2021 | 8434 | 0.420 |
Why?
|
Huntington Disease | 1 | 2019 | 1133 | 0.420 |
Why?
|
Optic Atrophy, Hereditary, Leber | 2 | 2023 | 49 | 0.420 |
Why?
|
Humans | 64 | 2024 | 746070 | 0.410 |
Why?
|
Optic Neuropathy, Ischemic | 2 | 2024 | 84 | 0.410 |
Why?
|
Pituitary Neoplasms | 1 | 2020 | 1307 | 0.400 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2024 | 2103 | 0.400 |
Why?
|
Herpesvirus 3, Human | 2 | 2023 | 157 | 0.400 |
Why?
|
Ophthalmology | 1 | 2018 | 514 | 0.390 |
Why?
|
Nervous System Diseases | 2 | 2021 | 1611 | 0.380 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4480 | 0.360 |
Why?
|
Adenoma | 1 | 2021 | 2138 | 0.360 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1392 | 0.350 |
Why?
|
Diplopia | 2 | 2021 | 212 | 0.330 |
Why?
|
Visual Field Tests | 2 | 2022 | 394 | 0.330 |
Why?
|
Diagnosis, Differential | 9 | 2021 | 12839 | 0.320 |
Why?
|
Eye | 2 | 2024 | 704 | 0.320 |
Why?
|
Tomography, Optical Coherence | 2 | 2020 | 2805 | 0.320 |
Why?
|
Brain | 7 | 2021 | 26597 | 0.320 |
Why?
|
Recurrence | 4 | 2023 | 8373 | 0.280 |
Why?
|
Fluorescein Angiography | 2 | 2023 | 1019 | 0.280 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1834 | 0.260 |
Why?
|
Parkinson Disease | 1 | 2019 | 2814 | 0.260 |
Why?
|
Health Planning Guidelines | 1 | 2006 | 151 | 0.250 |
Why?
|
Adrenal Cortex Hormones | 3 | 2022 | 1867 | 0.240 |
Why?
|
Hyperesthesia | 1 | 2024 | 23 | 0.240 |
Why?
|
Central Nervous System | 2 | 2022 | 1329 | 0.230 |
Why?
|
Eye Pain | 2 | 2021 | 46 | 0.230 |
Why?
|
Cranial Nerves | 1 | 2024 | 96 | 0.220 |
Why?
|
Neoplasms | 2 | 2024 | 21681 | 0.220 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 144 | 0.220 |
Why?
|
Parvovirinae | 1 | 2022 | 8 | 0.220 |
Why?
|
Health Priorities | 1 | 2006 | 369 | 0.210 |
Why?
|
National Health Programs | 1 | 2006 | 440 | 0.210 |
Why?
|
Female | 24 | 2024 | 382129 | 0.200 |
Why?
|
Meningitis, Cryptococcal | 1 | 2022 | 64 | 0.200 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 282 | 0.190 |
Why?
|
Waiting Lists | 1 | 2006 | 716 | 0.190 |
Why?
|
Hippocratic Oath | 1 | 2021 | 16 | 0.190 |
Why?
|
Mental Disorders | 1 | 2021 | 6637 | 0.190 |
Why?
|
Edema | 2 | 2022 | 755 | 0.190 |
Why?
|
Precipitating Factors | 1 | 2020 | 51 | 0.180 |
Why?
|
Sex Reassignment Procedures | 1 | 2021 | 62 | 0.180 |
Why?
|
Steroids | 2 | 2022 | 919 | 0.180 |
Why?
|
Moral Obligations | 1 | 2021 | 94 | 0.180 |
Why?
|
Peroxidase | 1 | 2023 | 600 | 0.180 |
Why?
|
Mobility Limitation | 1 | 2024 | 401 | 0.180 |
Why?
|
Doxycycline | 1 | 2021 | 328 | 0.170 |
Why?
|
Meninges | 1 | 2021 | 194 | 0.170 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 619 | 0.160 |
Why?
|
Retrospective Studies | 11 | 2024 | 78293 | 0.160 |
Why?
|
Adrenalectomy | 1 | 2021 | 341 | 0.160 |
Why?
|
Intracranial Hypertension | 1 | 2021 | 187 | 0.160 |
Why?
|
Fundus Oculi | 1 | 2020 | 532 | 0.160 |
Why?
|
Administration, Topical | 1 | 2020 | 688 | 0.160 |
Why?
|
Cerebellar Ataxia | 1 | 2019 | 144 | 0.150 |
Why?
|
Social Responsibility | 1 | 2021 | 385 | 0.150 |
Why?
|
Fertilization in Vitro | 1 | 2006 | 1279 | 0.150 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2022 | 653 | 0.150 |
Why?
|
Stroke | 1 | 2020 | 9692 | 0.150 |
Why?
|
Young Adult | 7 | 2024 | 57114 | 0.150 |
Why?
|
Headache | 2 | 2022 | 1223 | 0.150 |
Why?
|
Plasma Cells | 1 | 2021 | 589 | 0.150 |
Why?
|
Muscle Weakness | 1 | 2020 | 409 | 0.150 |
Why?
|
Inflammation | 6 | 2023 | 10591 | 0.150 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 700 | 0.140 |
Why?
|
Cocaine | 1 | 2022 | 982 | 0.140 |
Why?
|
Optic Nerve Injuries | 1 | 2018 | 145 | 0.140 |
Why?
|
Adult | 12 | 2024 | 214969 | 0.140 |
Why?
|
Sensation Disorders | 1 | 2017 | 156 | 0.140 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2018 | 246 | 0.130 |
Why?
|
Eye Movements | 1 | 2019 | 506 | 0.130 |
Why?
|
Accidental Falls | 1 | 2024 | 1034 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 3782 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2018 | 15341 | 0.130 |
Why?
|
Secondary Prevention | 1 | 2022 | 1520 | 0.130 |
Why?
|
Cerebral Infarction | 1 | 2020 | 978 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2020 | 513 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.130 |
Why?
|
Male | 16 | 2024 | 351098 | 0.120 |
Why?
|
Fatal Outcome | 1 | 2019 | 1825 | 0.120 |
Why?
|
Frontal Lobe | 1 | 2021 | 1405 | 0.120 |
Why?
|
China | 1 | 2020 | 2295 | 0.120 |
Why?
|
Aged | 9 | 2024 | 164222 | 0.110 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4119 | 0.110 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3584 | 0.110 |
Why?
|
Decompression, Surgical | 1 | 2018 | 591 | 0.110 |
Why?
|
Polymerase Chain Reaction | 1 | 2022 | 6058 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2021 | 889 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3027 | 0.100 |
Why?
|
Biopsy | 2 | 2021 | 6732 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2021 | 1066 | 0.100 |
Why?
|
Immunosuppressive Agents | 2 | 2023 | 4055 | 0.100 |
Why?
|
Visual Acuity | 2 | 2018 | 2574 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1624 | 0.090 |
Why?
|
Middle Aged | 10 | 2024 | 214419 | 0.090 |
Why?
|
Acute Disease | 1 | 2020 | 7116 | 0.080 |
Why?
|
tau Proteins | 1 | 2019 | 2013 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 11941 | 0.080 |
Why?
|
Oxygen | 1 | 2020 | 4175 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20145 | 0.080 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2767 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2018 | 5837 | 0.080 |
Why?
|
Amyloid beta-Peptides | 1 | 2021 | 3741 | 0.080 |
Why?
|
DNA | 1 | 2021 | 7199 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 1988 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5746 | 0.070 |
Why?
|
Cognition | 1 | 2024 | 6772 | 0.070 |
Why?
|
Immunotherapy | 1 | 2021 | 4594 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3100 | 0.060 |
Why?
|
Electroencephalography | 1 | 2019 | 6072 | 0.060 |
Why?
|
Incidence | 2 | 2024 | 20812 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7272 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7223 | 0.050 |
Why?
|
Knee | 1 | 2024 | 271 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6420 | 0.050 |
Why?
|
Touch | 1 | 2024 | 307 | 0.050 |
Why?
|
Family Characteristics | 1 | 2006 | 977 | 0.050 |
Why?
|
Meningoencephalitis | 1 | 2021 | 82 | 0.050 |
Why?
|
Internship and Residency | 1 | 2021 | 5763 | 0.050 |
Why?
|
Mutation | 2 | 2023 | 29620 | 0.050 |
Why?
|
Foot | 1 | 2024 | 557 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 396 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29072 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3730 | 0.040 |
Why?
|
Child | 2 | 2024 | 78469 | 0.040 |
Why?
|
Orbit | 1 | 2022 | 439 | 0.040 |
Why?
|
Hand | 1 | 2024 | 876 | 0.040 |
Why?
|
Adolescent | 2 | 2024 | 86212 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 538 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 835 | 0.040 |
Why?
|
Genitalia | 1 | 2017 | 113 | 0.040 |
Why?
|
Pain | 2 | 2022 | 4980 | 0.030 |
Why?
|
Central Nervous System Diseases | 1 | 2020 | 516 | 0.030 |
Why?
|
Gait | 1 | 2021 | 799 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2021 | 787 | 0.030 |
Why?
|
Risk Factors | 2 | 2024 | 72413 | 0.030 |
Why?
|
Adenine | 1 | 2021 | 976 | 0.030 |
Why?
|
Memory Disorders | 1 | 2021 | 1175 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2602 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2020 | 1318 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2022 | 3346 | 0.030 |
Why?
|
Piperidines | 1 | 2021 | 1634 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 3011 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2476 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2021 | 2617 | 0.020 |
Why?
|
Animals | 1 | 2020 | 166308 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14114 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 63664 | 0.020 |
Why?
|
Lung | 1 | 2020 | 9843 | 0.010 |
Why?
|
Schizophrenia | 1 | 2020 | 6838 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8359 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 57552 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2015 | 5052 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40505 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 53219 | 0.010 |
Why?
|
United States | 1 | 2021 | 70368 | 0.010 |
Why?
|
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(85)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_